Königsrainer A - Search Results

1

Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?

Löb S, Königsrainer A, Rammensee HG, Opelz G, Terness P. Löb S, et al. Among authors: konigsrainer a. Nat Rev Cancer. 2009 Jun;9(6):445-52. doi: 10.1038/nrc2639. Nat Rev Cancer. 2009. PMID: 19461669 Review.

2

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, Werner ER, Werner-Felmayer G, Weiss HG, Göbel G, Margreiter R, Königsrainer A, Fuchs D, Amberger A. Brandacher G, et al. Among authors: konigsrainer a. Clin Cancer Res. 2006 Feb 15;12(4):1144-51. doi: 10.1158/1078-0432.CCR-05-1966. Clin Cancer Res. 2006. PMID: 16489067

3

Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?

Löb S, Ebner S, Wagner S, Weinreich J, Schäfer R, Königsrainer A. Löb S, et al. Among authors: konigsrainer a. Transplantation. 2007 Feb 27;83(4):468-73. doi: 10.1097/01.tp.0000251646.09702.ec. Transplantation. 2007. PMID: 17318080

4

Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.

Lob S, Konigsrainer A, Schafer R, Rammensee HG, Opelz G, Terness P. Lob S, et al. Among authors: konigsrainer a. Blood. 2008 Feb 15;111(4):2152-4. doi: 10.1182/blood-2007-10-116111. Epub 2007 Nov 28. Blood. 2008. PMID: 18045970 Free article.

5

Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction?

Löb S, Königsrainer A. Löb S, et al. Among authors: konigsrainer a. Langenbecks Arch Surg. 2008 Nov;393(6):995-1003. doi: 10.1007/s00423-007-0245-7. Epub 2007 Dec 4. Langenbecks Arch Surg. 2008. PMID: 18064486 Review.

6

IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.

Löb S, Königsrainer A, Zieker D, Brücher BL, Rammensee HG, Opelz G, Terness P. Löb S, et al. Among authors: konigsrainer a. Cancer Immunol Immunother. 2009 Jan;58(1):153-7. doi: 10.1007/s00262-008-0513-6. Epub 2008 Apr 17. Cancer Immunol Immunother. 2009. PMID: 18418598 Free PMC article.

7

Morbid obesity and subsequent pancreatic cancer: pylorus-preserving pancreatoduodenectomy after laparoscopic sleeve gastrectomy.

Küper MA, Königsrainer I, Schmidt D, Kramer KM, Granderath FA, Schneider J, Löb S, Zieker D, Hartmann JT, Zdichavsky M, Königsrainer A, Brücher BL. Küper MA, et al. Among authors: konigsrainer a, konigsrainer i. Obes Surg. 2009 Mar;19(3):385-8. doi: 10.1007/s11695-008-9679-4. Epub 2008 Sep 25. Obes Surg. 2009. PMID: 18815848

8

Surgery of colorectal carcinoma in patients aged over 80.

Falch C, Kratt T, Beckert S, Kirschniak A, Zieker D, Königsrainer I, Löb S, Hartmann JT, Königsrainer A, Brücher BL. Falch C, et al. Among authors: konigsrainer a, konigsrainer i. Onkologie. 2009 Feb;32(1-2):10-6. doi: 10.1159/000184580. Epub 2009 Jan 20. Onkologie. 2009. PMID: 19209013

9

Local peritonectomy highly attracts free floating intraperitoneal colorectal tumour cells in a rat model.

Königsrainer I, Zieker D, Beckert S, von Weyhern C, Löb S, Falch C, Brücher BL, Königsrainer A, Glatzle J. Königsrainer I, et al. Among authors: konigsrainer a. Cell Physiol Biochem. 2009;23(4-6):371-8. doi: 10.1159/000218183. Epub 2009 May 6. Cell Physiol Biochem. 2009. PMID: 19471104 Free article.

10

Role of IDO in organ transplantation: promises and difficulties.

Löb S, Königsrainer A. Löb S, et al. Among authors: konigsrainer a. Int Rev Immunol. 2009;28(3-4):185-206. doi: 10.1080/08830180902989119. Int Rev Immunol. 2009. PMID: 19811321 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

587 results

Search Page